Insider · CIK 0001653052

Crombez Eric

Reports to the SEC for 3 companies · CLEVELAND, OH

sec.gov

Transactions

Companies

Filings

CIK

0001653052

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-15	ABEOABEONA THERAPEUTICS INC.S Sale	Director	SSale	−26.1K sh	$5.53	−$145K	37,313
2026-05-05	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Medical Officer	SSale	−344 sh	$24.96	−$8,586.24	111,189
2026-04-16	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Medical Officer	AAward	+34.7K sh	—	—	110,975
2026-04-16	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+60K sh	—	—	59,952
2026-03-02	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Medical Officer	SSale	−7,029 sh	$22.80	−$160K	76,301
2026-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Medical Officer	AAward	+11.6K sh	—	—	83,173
2026-02-02	ABEOABEONA THERAPEUTICS INC.S Sale	Director	SSale	−16.3K sh	$5.09	−$82.9K	63,456
2026-01-26	ABEOABEONA THERAPEUTICS INC.A Award	Director	AAward	+37.3K sh	—	—	79,740
2025-08-14	ABEOABEONA THERAPEUTICS INC.S Sale	Director	SSale	−4,718 sh	$6.93	−$32.7K	42,427
2025-05-05	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Medical Officer	SSale	−520 sh	$39.24	−$20.4K	71,530
2025-04-21	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Medical Officer	SSale	−242 sh	$35.11	−$8,496.62	71,680
2025-03-03	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Medical Officer	SSale	−8,945 sh	$42.10	−$377K	71,922
2025-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Medical Officer	AAward	+15K sh	—	—	80,215
2025-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Medical Officer	AAward	+16.8K sh	—	—	65,244
2025-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Ooption (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+30.2K sh	—	—	30,246
2025-01-31	ABEOABEONA THERAPEUTICS INC.A Award	Director	AAward	+36.1K sh	—	—	47,145
2024-08-13	ABEOABEONA THERAPEUTICS INC.A Award	Director	AAward	+11K sh	—	—	11,044
2024-05-02	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Medical Officer	SSale	−354 sh	$43.66	−$15.5K	48,431
2024-04-18	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Medical Officer	SSale	−142 sh	$44.10	−$6,262.2	48,785
2024-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+2,351 sh	—	—	2,351
2024-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+34.2K sh	—	—	34,200
2024-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	EVP and Chief Medical Officer	SSale	−1,238 sh	$53.76	−$66.6K	48,927
2024-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Medical Officer	AAward	+19.4K sh	—	—	49,912
2023-09-27	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+2,351 sh	—	—	2,351
2023-05-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	EVP and Chief Medical Officer	AAward	+8,362 sh	—	—	8,362
2023-05-01	RAREUltragenyx Pharmaceutical Inc.A Award	EVP and Chief Medical Officer	AAward	+4,658 sh	—	—	30,512
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−128K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−80.4K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−50K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−50K sh	—	—	0
2017-02-01	Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2016-02-01	Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
May 154
Crombez Eric0001493152-26-023912
SEC(opens sec.gov)
May 64
Crombez Eric0001193125-26-208632
SEC(opens sec.gov)
Apr 204
Crombez Eric0001193125-26-164257
SEC(opens sec.gov)
Mar 34
Crombez Eric0001193125-26-089104
SEC(opens sec.gov)
Feb 24
Crombez Eric0001493152-26-004805
SEC(opens sec.gov)
Jan 274
Crombez Eric0001493152-26-003808
SEC(opens sec.gov)
Aug 154
Crombez Eric0001641172-25-024384
SEC(opens sec.gov)
May 54
Crombez Eric0000950170-25-063792
SEC(opens sec.gov)
Mar 44
Crombez Eric0000950170-25-032794
SEC(opens sec.gov)
Feb 34
Crombez Eric0001493152-25-004753
SEC(opens sec.gov)
Aug 144
Crombez Eric0001493152-24-032395
SEC(opens sec.gov)
May 34
Crombez Eric0000950170-24-052788
SEC(opens sec.gov)
Apr 194
Crombez Eric0000950170-24-046055
SEC(opens sec.gov)
Mar 54
Crombez Eric0000950170-24-026635
SEC(opens sec.gov)

Companies

Address

6555 CARNEGIE AVE., 4TH FLOOR

CLEVELAND, OH, 44103